Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RoActemra in active rheumatoid arthritis
NCT01254331Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2011
- Primary completion
- Feb 2013
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Feb 2011; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01254331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254331.